WOMENS GENTLE LAXATIVE

openFDA label record#

This page contains supplementary openFDA label data. For the canonical label presentation, use the corresponding DailyMed Structured Product Label.

Verified complete openFDA source JSON (canonical bytes are SHA-256 checked before publication)

Brand name: WOMENS GENTLE LAXATIVE
Generic name: BISACODYL
Manufacturer: TARGET CORPORATION
Product type: HUMAN OTC DRUG
SPL set ID: 7cabd434-f48f-a16a-e053-2991aa0a2bb3
SPL ID: 86a77991-3dc9-0e98-e053-2a91aa0a61b7
Version: 3
Effective date: 2019-04-16
Source export date: 2026-09-28
Source partition: 13
Source file: https://download.open.fda.gov/drug/label/drug-label-0013-of-0014.json.zip
Source object key: raw/openfda/drug-label/2026-09-28/e78bf8aa9f90ab13e640d254dfbd4fe5bfeca4995ec5f9d51bce3356e249cab7/drug-label-0013-of-0014.json.zip
Source manifest SHA-256: cd2e66336a5cd2223fa3995098fdbdb84c6a7ee5c0a4addb236ccb22dd1e6887
Import run: 20260929T050834Z
Imported at: 2026-09-29 06:35:48

Harmonized routes table
Harmonized routes
ORAL

Harmonized identifier links#

Every typed identifier imported from the complete openFDA harmonization object is paginated here; values are not reduced to a first match.

Harmonized identifiers page 1 of 1 · 11 matching rows.

Type, Scope, Identifier table
Type	Scope	Identifier	Source field
application number		part334	openfda.application_number
brand name		WOMENS GENTLE LAXATIVE	openfda.brand_name
generic name		BISACODYL	openfda.generic_name
manufacturer name		TARGET CORPORATION	openfda.manufacturer_name
ndc	package	11673-151-52	openfda.package_ndc
ndc	product	11673-151	openfda.product_ndc
ndc11	package	11673015152	derived:openfda.package_ndc
rxcui		308753	openfda.rxcui
spl id		86a77991-3dc9-0e98-e053-2a91aa0a61b7	id
spl set id		7cabd434-f48f-a16a-e053-2991aa0a2bb3	set_id
unii		10X0709Y6I	openfda.unii

Warnings cross-check#

openFDA text is shown for search and cross-checking; DailyMed SPL is canonical.

Warnings sections page 1 of 1 · 2 matching rows.

warnings

Warning: Do not use if you cannot swallow without chewing. Ask a doctor before use if you have: stomach pain, nausea or vomiting; A sudden change in bowel habits that lasts more than two weeks. When using this product: Do not chew or crush tablet(s); Do not use within 1 hour after taking an antacid or milk; Do not use this product if you have stomack discomfort, faintness or cramps.

warnings table

<table border="0" width="100%"> <tbody> <tr> <td> <paragraph>Warning: Do not use if you cannot swallow without chewing.</paragraph> <paragraph>Ask a doctor before use if you have: stomach pain, nausea or vomiting; A sudden change in bowel habits that lasts more than two weeks.</paragraph> <paragraph>When using this product: Do not chew or crush tablet(s); Do not use within 1 hour after taking an antacid or milk; Do not use this product if you have stomack discomfort, faintness or cramps.</paragraph> </td> </tr> </tbody> </table>

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.